|
1
|
Tharmapalan P, Mahendralingam M, Berman HK
and Khokha R: Mammary stem cells and progenitors: Targeting the
roots of breast cancer for prevention. EMBO J. 38:e1008522019.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Bray F, Ferlay J, Soerjomataram I, Siegel
RL, Torre LA and Jemal A: Global cancer statistics 2018: GLOBOCAN
estimates of incidence and mortality worldwide for 36 cancers in
185 countries. CA Cancer J Clin. 68:394–424. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Katsura C, Ogunmwonyi I, Kankam HK and
Saha S: Breast cancer: Presentation, investigation and management.
Br J Hosp Med (Lond). 83:1–7. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Prat A, Pineda E, Adamo B, Galván P,
Fernández A, Gaba L, Díez M, Viladot M, Arance A and Muñoz M:
Clinical implications of the intrinsic molecular subtypes of breast
cancer. Breast. 24 (Suppl 2):S26–S35. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Yin L, Duan JJ, Bian XW and Yu SC:
Triple-negative breast cancer molecular subtyping and treatment
progress. Breast Cancer Res. 22:612020. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Zhu Y, Zhu X, Tang C, Guan X and Zhang W:
Progress and challenges of immunotherapy in triple-negative breast
cancer. Biochim Biophys Acta Rev Cancer. 1876:1885932021.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Cho B, Han Y, Lian M, Colditz GA, Weber
JD, Ma C and Liu Y: Evaluation of racial/ethnic differences in
treatment and mortality among women with triple-negative breast
cancer. JAMA Oncol. 7:1016–1023. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Zhang H, Chen Z, Zhou J, Gu J, Wu H, Jiang
Y, Gao S, Liao Y, Shen R, Miao C and Chen W: NAT10 regulates
neutrophil pyroptosis in sepsis via acetylating ULK1 RNA and
activating STING pathway. Commun Biol. 5:9162022. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Li K, Qiu J, Pan J and Pan JP: Pyroptosis
and its role in cervical cancer. Cancers (Basel). 14:57642022.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Wan SC, Ye MJ, Yang QC, Zhang T, Zhang MJ,
Ma XB, Xu JM, Wang S, Wu ZZ, Yang LL, et al: Diselenide-based
dual-responsive prodrug as pyroptosis inducer potentiates cancer
immunotherapy. Adv Healthc Mater. 12:e22021352023. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Wang C, Yang T, Xiao J, Xu C, Alippe Y,
Sun K, Kanneganti TD, Monahan JB, Abu-Amer Y, Lieberman J and
Mbalaviele G: NLRP3 inflammasome activation triggers gasdermin
D-independent inflammation. Sci Immunol. 6:eabj38592021. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Swanson KV, Deng M and Ting JP: The NLRP3
inflammasome: Molecular activation and regulation to therapeutics.
Nat Rev Immunol. 19:477–489. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Man SM, Karki R and Kanneganti TD:
Molecular mechanisms and functions of pyroptosis, inflammatory
caspases and inflammasomes in infectious diseases. Immunol Rev.
277:61–75. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Jingushi K, Uemura M, Ohnishi N, Nakata W,
Fujita K, Naito T, Fujii R, Saichi N, Nonomura N, Tsujikawa K and
Ueda K: Extracellular vesicles isolated from human renal cell
carcinoma tissues disrupt vascular endothelial cell morphology via
azurocidin. Int J Cancer. 142:607–617. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Shafer WM, Martin LE and Spitznagel JK:
Cationic antimicrobial proteins isolated from human neutrophil
granulocytes in the presence of diisopropyl fluorophosphate. Infect
Immun. 45:29–35. 1984. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Di Gennaro A, Kenne E, Wan M, Soehnlein O,
Lindbom L and Haeggström JZ: Leukotriene B4-induced changes in
vascular permeability are mediated by neutrophil release of
heparin-binding protein (HBP/CAP37/azurocidin). FASEB J.
23:1750–1757. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Naito T, Jingushi K, Ueda K and Tsujikawa
K: Azurocidin is loaded into small extracellular vesicles via its
N-linked glycosylation and promotes intravasation of renal cell
carcinoma cells. FEBS Lett. 595:2522–2532. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Sun JK, Shen X, Sun XP, Wang X, Zhang WH,
Shi QK and Mu XW: Heparin-binding protein as a biomarker of
gastrointestinal dysfunction in critically ill patients: A
retrospective cross-sectional study in China. BMJ Open.
10:e0363962020. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Eisenhauer EA, Therasse P, Bogaerts J,
Schwartz LH, Sargent D, Ford R, Dancey J, Arbuck S, Gwyther S,
Mooney M, et al: New response evaluation criteria in solid tumours:
Revised RECIST guideline (version 1.1). Eur J Cancer. 45:228–247.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Zhang J and Wei K: Necrosulfonamide
reverses pyroptosis-induced inhibition of proliferation and
differentiation of osteoblasts through the NLRP3/caspase-1/GSDMD
pathway. Exp Cell Res. 405:1126482021. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Yan S, Jiang Y, Yu T, Hou C, Xiao W, Xu J,
Wen H, Wang J, Li S, Chen F, et al: Shengjiang San alleviated
sepsis-induced lung injury through its bidirectional regulatory
effect. Chin Med. 18:392023. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Xie Y, Hu Y, Zhou N, Yao C, Wu L, Liu L
and Chen F: CAR T-cell therapy for triple-negative breast cancer:
Where we are. Cancer Lett. 491:121–131. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Xie Q, Yang Z, Huang X, Zhang Z, Li J, Ju
J, Zhang H and Ma J: Ilamycin C induces apoptosis and inhibits
migration and invasion in triple-negative breast cancer by
suppressing IL-6/STAT3 pathway. J Hematol Oncol. 12:602019.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Del Prete A, Schioppa T, Tiberio L,
Stabile H and Sozzani S: Leukocyte trafficking in tumor
microenvironment. Curr Opin Pharmacol. 35:40–47. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Blanco M, Collazo-Lorduy A, Yanguas-Casás
N, Calvo V and Provencio M: Unveiling the role of the tumor
microenvironment in the treatment of follicular lymphoma. Cancers
(Basel). 14:21582022. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Linder A, Soehnlein O and Akesson P: Roles
of heparin-binding protein in bacterial infections. J Innate Immun.
2:431–438. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Fisher J and Linder A: Heparin-binding
protein: A key player in the pathophysiology of organ dysfunction
in sepsis. J Intern Med. 281:562–574. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Yang M, Li J, Gu P and Fan X: The
application of nanoparticles in cancer immunotherapy: Targeting
tumor microenvironment. Bioact Mater. 6:1973–1987. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Soehnlein O, Xie X, Ulbrich H, Kenne E,
Rotzius P, Flodgaard H, Eriksson EE and Lindbom L:
Neutrophil-derived heparin-binding protein (HBP/CAP37) deposited on
endothelium enhances monocyte arrest under flow conditions. J
Immunol. 174:6399–6405. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Pérez-Herrero E and Fernández-Medarde A:
Advanced targeted therapies in cancer: Drug nanocarriers, the
future of chemotherapy. Eur J Pharm Biopharm. 93:52–79. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Vervloessem T, Akl H, Tousseyn T, De Smedt
H, Parys JB and Bultynck G: Reciprocal sensitivity of diffuse large
B-cell lymphoma cells to Bcl-2 inhibitors BIRD-2 versus venetoclax.
Oncotarget. 8:111656–111671. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Mendez DL, Akey IV, Akey CW and Kranz RG:
Oxidized or reduced cytochrome c and axial ligand variants all form
the apoptosome in vitro. Biochemistry. 56:2766–2769. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Jiang L, Li XP, Dai YT, Chen B, Weng XQ,
Xiong SM, Zhang M, Huang JY, Chen Z and Chen SJ: Multidimensional
study of the heterogeneity of leukemia cells in t(8;21) acute
myelogenous leukemia identifies the subtype with poor outcome. Proc
Natl Acad Sci USA. 117:20117–20126. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Kovacs SB and Miao EA: Gasdermins:
Effectors of pyroptosis. Trends Cell Biol. 27:673–684. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Xia X, Wang X, Cheng Z, Qin W, Lei L,
Jiang J and Hu J: The role of pyroptosis in cancer: pro-cancer or
pro-‘host’? Cell Death Dis. 10:6502019. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Shi J, Zhao Y, Wang K, Shi X, Wang Y,
Huang H, Zhuang Y, Cai T, Wang F and Shao F: Cleavage of GSDMD by
inflammatory caspases determines pyroptotic cell death. Nature.
526:660–665. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Zuo Y, Chen L, Gu H, He X, Ye Z, Wang Z,
Shao Q and Xue C: GSDMD-mediated pyroptosis: A critical mechanism
of diabetic nephropathy. Expert Rev Mol Med. 23:e232021. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Chung C, Seo W, Silwal P and Jo EK:
Crosstalks between inflammasome and autophagy in cancer. J Hematol
Oncol. 13:1002020. View Article : Google Scholar : PubMed/NCBI
|
